Psychiatric Sleep Disturbances: March 2016
Keck School of Medicine of USC and Psychiatric Annals
Table of Contents
Insomnia and Depression: A Reciprocal Relationship
Daniel D. Herrick, MD; and Michael J. Sateia, MD
Sleep Disturbances in Posttraumatic Stress Disorder: Updated Review and Implications for Treatment
Erin Koffel, PhD; Imran S. Khawaja, MBBS, FAASM; and Anne Germain, PhD
The Relationship Between Sleep Disturbance, Suicidal Ideation, Suicide Attempts, and Suicide Among Adults: A Systematic Review
Wilfred R. Pigeon, PhD; Todd M. Bishop, PhD; and Caitlin E. Titus, MS
Obstructive Sleep Apnea and Depression: A Review
Imran S. Khawaja, MBBS, FAASM; Louis Kazaglis, MD; Ali Hashmi, MD; Khurshid A. Khurshid, MD, FAASM; Chad Eiken, RPSGT, CCSH; and Thomas D. Hurwitz, MD
Sleep and Schizophrenia
Richard C. Holbert, MD; Khurshid A. Khurshid, MD, FAASM; Robert Averbuch, MD; and Imran S. Khawaja, MBBS, FAASM
Sponsorship Statement: This CME activity is jointly sponsored by Keck School of Medicine of USC and Psychiatric Annals.
Support Statement: There is no commercial support for this activity.
1. Identify the frequency, nature, pathophysiology, and complications of insomnia associated with major depressive disorder.
2. Identify sleep disturbances that co-occur with posttraumatic stress disorder.
3. Identify the role that sleep disturbance plays in the etiology of suicidal ideation, suicide attempts, and suicide.
4. Identify the frequency, nature, pathophysiology, and comorbid relationship of obstructive sleep apnea and depression.
5. Describe the frequency, nature, and pathophysiology of sleep problems in patients with schizophrenia.
Faculty names and affiliations: See authors above
Guest Editors:Thomas D. Hurwitz, MD; and Imran S. Khawaja, MBBS, FAASM
Reviewer names: Jan Fawcett, MD, Editor, Psychiatric Annals; Andrew A. Nierenberg, MD, CME Coordinator, Psychiatric Annals
Disclosure statement: In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears at the beginning of each CME-accredited article in this issue and also on this page.
Faculty members report the following financial relationships: Jan Fawcett, MD, has no relevant financial relationships to disclose. Andrew A. Nierenberg, MD, has disclosed the following relevant financial relationships: Appliance Computing Inc. (Mindsite); Astra Zeneca; Brain Cells, Inc.; Brandeis University; Bristol Myers Squibb; Clintara, Dianippon Sumitomo/Sepracor; Eli Lilly and Company; EpiQ, Forest; Johnson and Johnson; Labopharm; Merck; Methylation Science; Novartis; PamLabs; PGx Health; Shire; Schering-Plough; Sunovion; Takeda/Lundbeck Pharmaceuticals; Targacept; Teva: Consultant. APSARD; Belvoir Publishing; Boston Center for the Arts; University of Texas Southwestern Dallas; Hillside Hospital; American Drug Utilization Review; American Society for Clinical Psychopharmacology; Bayamon Region Psychiatric Society; Baystate Medical Center; Canadian Psychiatric Association; Columbia University; Douglas Hospital/McGill University; IMEDEX; International Society for Bipolar Disorders; Israel Society for Biological Psychiatry; John Hopkins University; MJ Consulting; Massachusetts Association of College Counselors; Medscape; MBL Publishing; Physicians Postgraduate Press; Ryan Licht Sang Foundation; Slack Publishing; SUNY Buffalo; University of Florida; University of Miami; University of Wisconsin; University of Pisa; SciMed: Honoraria / travel expenses. Appliance Computing, Inc.; Brain Cells, Inc.: Stock options. AHRQ; Cephalon; Forest; Mylan; NIMH; PamLabs; Pfizer Pharmaceuticals; Takeda; Elan; Shire: Grant / research support.
Authors report the following financial relationships: Daniel D. Herrick has no relevant financial relationships to disclose. Michael J. Sateia has no relevant financial relationships to disclose. Erin Koffel has no relevant financial relationships to disclose. Imran S. Khawaja has no relevant financial relationships to disclose. Anne Germain has no relevant financial relationships to disclose. Wilfred R. Pigeon discloses fees received for non-CME services from Merck & Co. and the Sharpe Dohme Company (a pharmaceutical manufacturer). Todd M. Bishop has no relevant financial relationships to disclose. Caitlin E. Titus has no relevant financial relationships to disclose. Louis Kazaglis has no relevant financial relationships to disclose. Ali Hashmi has no relevant financial relationships to disclose. Khurshid A. Khurshid has no relevant financial relationships to disclose. Chad Eiken has no relevant financial relationships to disclose. Richard C. Holbert has no relevant financial relationships to disclose. Robert Averbuch has no relevant financial relationships to disclose.
The staff of Keck School of Medicine of USC and Psychiatric Annals have disclosed no relevant financial relationships. Signed disclosures are on file at Keck School of Medicine of USC.
Accreditation statement(s): This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Keck School of Medicine of USC and SLACK Incorporated. The Keck School of Medicine of USC is accredited by the ACCME to provide continuing medical education for physicians.
Credit designation: The Keck School of Medicine of USC designates this enduring material for a maximum of 3 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Release date: March 1, 2016. Expiration Date: March 31, 2019.
How to participate: To participate in this CME activity, you must read the learning objectives, answer the pretest questions, read the articles, complete the CME posttest, and complete the evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 70% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Keck School of Medicine of USC will issue an AMA PRA Category 1 Credit(s)™ certificate.
Target audience: This CME activity is primarily targeted to patient-caring psychiatrists, physicians specializing in psychiatry and others allied to the field. There are no specific background requirements for participants taking this activity. Learning objectives and author disclosures are found at the beginning of each CME article.
Unlabeled and investigational usage statement: The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage.
Copyright statement: Copyright © 2016 by SLACK Incorporated. All rights reserved. No part of this publication may be reproduced without prior written consent of the publisher.